NSE filing, NSE: KOTARISUG. Summary written from the filing by ALFA Finder's alert engine.
Kothari Sugars & Chemicals Ltd: key numbers
- Share price
- ₹23.11
- Market cap
- ₹191.6 Cr
- Revenue (annual)
- ₹246.8 Cr
- Net profit (annual)
- ₹6.61 Cr
- P/E (TTM)
- 35.2×Sector 27.1×
- Promoter holding
- 73.53%+0.00% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kothari Sugars & Chemicals Ltd
All →Kothari Sugars & Chemicals Acquisition
Kothari Sugars and Chemicals Limited received an NCLT order directing shareholder and unsecured creditor meetings to consider its proposed amalgamation with Kothari Petrochemicals Limited.
Kothari Sugars & Chemicals Acquisition
Kothari Sugars and Chemicals Limited received an NSE 'no objection' observation letter for its proposed amalgamation with Kothari Petrochemicals Limited. The scheme remains subject to further approvals.
Kothari Sugars & Chemicals Q1 FY27 Results: Net Profit ₹0.1 Cr, Down 91.7% YoY
Kothari Sugars & Chemicals Ltd reported revenue from operations of ₹83.4 Cr (+25.0% YoY) and net profit of ₹0.1 Cr (-91.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr · -91.7% YoY
Kothari Sugars & Chemicals Annual General Meeting
Kothari Sugars and Chemicals Limited held its 65th Annual General Meeting on August 13, 2026. Shareholders approved audited financial statements and the re-appointment of Mr. Arjun B. Kothari.
Kothari Sugars & Chemicals Board Meeting Date
Kothari Sugars and Chemicals Limited scheduled a board meeting for August 13, 2026, to consider and approve unaudited financial results for the quarter ended June 2026.
Kothari Sugars & Chemicals Annual General Meeting
Kothari Sugars and Chemicals convened its 65th AGM for August 13, 2026. Key agenda items include adopting financial statements and re-appointing Director Arjun B. Kothari.
- Value
- ₹0.01 Cr
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.